News
Public · Published
An IVF Company Bought 146,432 XRP Last Year, Then Sold It All
Newgenivf Group, a fertility clinic operator, disclosed in a Nasdaq filing that it bought 146,432 XRP tokens during 2025 and sold all of them before December 31. The transactions resulted in a total profit of $10,849.
Published:
Updated:
What happened
Newgenivf Group, a fertility clinic operator, disclosed in a Nasdaq filing that it bought 146,432 XRP tokens during 2025 and sold all of them before December 31. The transactions resulted in a total profit of $10,849.
Confirmed
Global impact / market context
This shows a small company using cash available to invest in a digital token. The modest profit from buying and selling XRP could encourage other firms to try similar trades. Investors might watch how companies handle digital asset purchases in their filings.
Analyst inference
XRP is a digital token used for payments. When companies hold or trade such tokens, it adds to their cash available and can affect how they pay for operations. This news may spark interest in how businesses interact with cryptocurrency markets.
Analyst inference
What to watch
- Newgenivf Group's filing shows it sold all 146,432 XRP by the end of 2025. Investors can look for future regulatory updates from the company that might mention why it chose to exit its position. Confirmed
- Analysts might propose tracking whether Newgenivf's move into and out of XRP is a one-time event or part of a broader plan. Future company statements could reveal its intentions regarding digital asset investments. Proposed
- If other small companies see this profitable round trip, they could also buy and sell digital tokens, influencing demand for XRP and similar assets in the market. Watch for other corporate filings mentioning crypto trades. Analyst inference
Affected assets
- SOL — Solana
- XRP — XRP